商品分类

浏览历史

B21576	淫羊藿苷
源叶	分析标准品,HPLC≥98%

英文名：
Icariin

别名：
淫羊藿甙，淫羊藿提取物

CAS号：
489-32-7

分子式：
C₃₃H₄₀O₁₅

分子量：
676.67

MDL：
MFCD00210516

核磁/质谱：

品牌	货号	产品规格	价格(RMB)	库存（上海）	北京	武汉	南京	数量	计量单位	加入购物车...
源叶	B21576-20mg	分析标准品,HPLC≥98%	￥100.00元	>10	2	1	4		EA	加入购物车
源叶	B21576-100mg	分析标准品,HPLC≥98%	￥300.00元	>10	3	-	2		EA	加入购物车

大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》，到货后将短信提示。
提交

产品介绍

参考文献(100篇)

质检证书(COA)

摩尔浓度计算器

相关产品

熔点： 223-225°C

沸点： 948.5 °C at 760 mmHg

比旋光度： D15 -87.09° (in pyridine)

外观：淡黄色针状结晶粉末

溶解性： DMSO：100mg/ml（超声）

储存条件： 2-8℃

注意：部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

100. [4.4] Chen Yangfeng et al."In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb."Frontiers in Pharmacology.2024 Jul;15:

99. [IF=0] Huiling Liu et al."High-strength double-network silk fibroin based hydrogel loaded with Icariin and BMSCs to inhibit osteoclasts and promote osteogenic differentiation to enhance bone repair."Biomaterials Advances".2024 Apr;:213856

98. [IF=1.7] Luo Wei et al."Icariin ameliorates viral myocarditis by inhibiting TLR4-mediated ferroptosis."Asian Pacific Journal of Tropical Biomedicine".2024 Mar;14(3):106

97. [IF=6] Dong Xie et al."Pharmacodynamic material basis and mechanism of Tenghuang Jiangu Wan on osteoarthritis using UPLC-Q-TOF-MS integrated with target network pharmacology."Arabian Journal of Chemistry".2024 Apr;17:105711

96. [IF=5.8] Zhao Mei et al."Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer."Cancer Cell International".2024 Dec;24(1):1-15

95. [IF=7.9] Yankai Dong et al."Effect of icariin on depressive behaviour in rat pups. Evidences for its mechanism of action by integrating network pharmacology, metabolomics and gut microbiota composition."PHYTOMEDICINE".2024 Apr;126:155422

94. [IF=5.4] Xinying Fu et al."Guhan Yangsheng Jing mitigates hippocampal neuronal pyroptotic injury and magnifies learning and memory capabilities in sleep deprived mice via the NLRP3/Caspase1/GSDMD signaling pathway."JOURNAL OF ETHNOPHARMACOLOGY".2024 Feb;:117972

93. [IF=8.4] Ting An et al."De novo biosynthesis of anticarcinogenic icariin in engineered yeast."METABOLIC ENGINEERING.2023 Nov;80:207

92. [IF=5.8] Xu Wenjing et al."Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect."Cancer Cell International.10.1186/s12935-023-03042-1

91. [IF=8.2] Shaorong Li et al."Dual-functional 3D-printed porous bioactive scaffold enhanced bone repair by promoting osteogenesis and angiogenesis."Materials Today Bio.2024 Feb;24:100943

90. [IF=4.7] Xu Zhang et al."Rhein: A potent immunomodulator empowering largemouth bass against MSRV infection."FISH & SHELLFISH IMMUNOLOGY.2024 Jan;144:109284

89. [IF=1.7] Zhouyi Zhang et al."Revealing the differences in phenolics in different parts of Taraxacum mongolicum using UPLC-MS/MS."Phytochemistry Letters.2023 Aug;56:13

88. [IF=5.572] Zhen Zhao et al."An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro."FOOD AND CHEMICAL TOXICOLOGY.2023 Jun;176:

87. [IF=6.208] Jiaqi Zhang et al."The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2023 Jan;24(8):7646

86. [9.273] Jia Zeng et al."Bone Mesenchymal Stem Cell-derived Exosomes Involved Co-delivery and Synergism Effect with Icariin via Mussel-inspired Multifunctional Hydrogel for Cartilage Protection."Asian Journal of Pharmaceutical Sciences.2023 Mar;:100799

85. [2.626] Ma, Rui-jiao et al."Kunxian Capsule Extract Inhibits Angiogenesis in Zebrafish Embryos via PI3K/AKT-MAPK-VEGF Pathway."Chinese Journal of Integrative Medicine.2022 Dec;:1-9

84. [6.438] Wenjing Xu et al."Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer."BIOFACTORS.2022 Dec;:

83. [7.31] Mengxia Wang et al."Neuroprotective Mechanism of Icariin on Hypoxic Ischemic Brain Damage in Neonatal Mice."Oxidative Medicine and Cellular Longevity.2022 Nov 15;2022:1330928

82. [IF=1.698] Jinyan Wu et al."Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS."International Journal of Analytical Chemistry.2022 Oct 15;2022:142380

81. [IF=3.571] Yuhao Zhang et al."A novel strategy integrating gas phase fractionation with staggered mass range and LC-MS/MS molecular network for comprehensive metabolites profiling of Gui Ling Ji in rats."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Jan;222

80. [IF=5.738] Fu Yanjin et al."Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer."Frontiers in Oncology.2022 Sep;0:4742

79. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747

78. [IF=5.895] Fang Liu et al."Co-Immobilizing Two Glycosidases Based on Cross-Linked Enzyme Aggregates to Enhance Enzymatic Properties for Achieving High Titer Icaritin Biosynthesis."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY.2022;XXXX(XXX):XXX-XXX

77. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231

76. [IF=6.064] Jia-Jun Huang et al."Computer-Aided Design of α-L-Rhamnosidase to Increase the Synthesis Efficiency of Icariside I."Frontiers in Bioengineering and Biotechnology.2022; 10: 926829

75. [IF=2.63] Li Hangchao et al."Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling Pathway."Evidence-based Complementary and Alternative Medicine. 2022;2022:

74. [IF=6.53] Pan Sun et al."Jiangu granule ameliorated OVX rats bone loss by modulating gut microbiota-SCFAs-Treg/Th17 axis."BIOMEDICINE & PHARMACOTHERAPY. 2022 Jun;150:112975

73. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177

72. [IF=3.935] Junmao Li et al."Comprehensive chemical profiling of the flowers of Citrus aurantium L. var. amara Engl. and uncovering the active ingredients of lipid lowering."J Pharmaceut Biomed. 2022 Mar;211:114621

71. [IF=1.672] Yang Lihong et al."Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro."Cytotechnology. 2019 Dec;71(6):1109-1120

70. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21

69. [IF=1.986] Yang Du et al."Investigation of labile protein-ligand interactions by native electrospray ionization mass spectrometry."Int J Mass Spectrom. 2021 Apr;462:116524

68. [IF=2.447] Ling Sun et al."Icariin inhibits oral squamous cell carcinoma cell proliferation and induces apoptosis via inhibiting the NF‑κB and PI3K/AKT pathways."Exp Ther Med. 2021 Sep;22(3):1-7

67. [IF=2.984] Xiao-Hua Yang et al."Flavonoids from Epimedium pubescens: extraction and mechanism, antioxidant capacity and effects on CAT and GSH-Px of Drosophila melanogaster."Peerj. 2020 Jan;8:e8361

66. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950

65. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556

64. [IF=3.645] Junfeng Li et al."An LC-MS/MS method for simultaneous quantification of 11 components of Xian-Xiong-Gu-Kang in the plasma of osteoarthritic rats and pharmacokinetic analysis."J Sep Sci. 2021 Sep;44(18):3386-3397

63. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80

62. [IF=3.765] Shun Liu et al."Simultaneous determination of seven effective components in Shenkui Tongmai granules based on UHPLC-MS/MS."J Pharm Pharmacol. 2021 Apr;73(6):758-766

61. [IF=4.36] Kun Shi et al."Epimedii Folium and Curculiginis Rhizoma ameliorate lipopolysaccharides-induced cognitive impairment by regulating the TREM2 signaling pathway."J Ethnopharmacol. 2022 Feb;284:114766

60. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137

59. [IF=4.432] Luya Pu et al."Icariin arrests cell cycle progression and induces cell apoptosis through the mitochondrial pathway in human fibroblast-like synoviocytes."Eur J Pharmacol. 2021 Dec;912:174585

58. [IF=5.34] Liping Zhang et al."Cardioprotective effect of icariin against myocardial fibrosis and its molecular mechanism in diabetic cardiomyopathy based on network pharmacology: Role of ICA in DCM."Phytomedicine. 2021 Oct;91:153607

57. [IF=2.419] Lu Wang et al."Characterization of interaction property of multi-components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry."Rapid Communications In Mass Spectrometry. 2016 Au

56. [IF=3.935] Tong Wang et al."Metabolic profiling of icariin in rat feces, urine, bile and plasma after oral administration using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry."J Pharmaceut Biomed. 2019 May;168:155

55. [IF=4.411] Tao Cheng et al."Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats."Molecules. 2015 Dec;20(12):21274-21286

54. [IF=4.545] Yan-dan Zhou et al."Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway."Biomed Pharmacother. 2019 Jan;109:2309

53. [IF=5.64] Wu Dousheng et al."Oleanolic Acid Induces the Type III Secretion System of Ralstonia solanacearum."Front Microbiol. 2015 Dec;0:1466

52. [IF=6.529] Congyan Liu et al."Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats."Biomed Pharmacother. 2017 Oct;94:1048

51. Cheng, Tao, et al. "Comparative pharmacokinetics study of icariin and icariside II in rats." Molecules 20.12 (2015): 21274-21286.https://doi.org/10.3390/molecules201219763

50. Yang, Lihong, et al. "Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro." Cytotechnology 71.6 (2019): 1109-1120.https://doi.org/10.1007/s10616-019-00348-9

49. Liu, Congyan, et al. "Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats." Biomedicine & Pharmacotherapy 94 (2017): 1048-1056.https://doi.org/10.1016/j.biopha.2017.07.163

48. Jia, Xiaohe, et al. "Design, preparation, surface recognition properties, and characteristics of icariin molecularly imprinted polymers." Cogent Chemistry 1.1 (2015): 1059597.

47. Wang, Lu, et al. "Characterization of interaction property of multi‐components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry." Rapid Communications in Mass Spectrometry 30 (2

46. Wang, Lu, et al. "Characterization of interaction property of multi‐components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry." Rapid Communications in Mass Spectrometry 30 (2

45. 黄楷迪,刘敬霞,牛阳,马学琴,张婷,卜凡淑,任慧,郭盛,钱大玮,段金廒.回药扎里奴思方UPLC指纹图谱结合多成分含量测定的质控方法研究[J].南京中医药大学学报,2021,37(01):77-82.

44. 兰海,刘欣妍,余玲,莫诺兰,张燕,郭子右,吴清.大孔树脂纯化淫羊藿中朝藿定与淫羊藿苷工艺研究[J].中草药,2020,51(17):4473-4481.

43. 刘聪燕,李瑞云,马程遥,刘玉萍,瞿鼎,李晓琦,陈彦.壳聚糖交联介孔二氧化硅固定化β-葡萄糖苷酶生物转化淫羊藿苷研究[J].中草药,2021,52(03):685-691.

42. 武通,陈东宁,许占江.基于VEGF/VEGFR-2信号通路研究淫羊藿苷促进大鼠胫骨干骨折愈合的作用机制[J].浙江中医药大学学报,2021,45(03):282-288+293.

41. 何俊慧,韦洁,李冬梅,何飞,陆国寿,韦冬梅,李懿,赵成坚,韦桂宁,李力.基于TLR4/NF-κB通路探讨蛤蚧提取物对利血平诱导抑郁大鼠神经炎症的影响[J].中国实验方剂学杂志,2021,27(09):56-62.

40. 范小龙,陈冉,吴婉琴,刘国姣,黄坤,江丰.液相色谱串联质谱法测定食品中淫羊藿苷等20种功能成分[J].食品与机械,2021,37(01):86-93+98.

39. 李琦,孙贵才.淫羊藿苷对骨髓间充质干细胞铁死亡及向心肌样细胞分化的影响[J].中国组织工程研究,2021,25(13):1988-1992.

38. 彭静, 马益华, 陈彦,等. 固定化蜗牛酶同时生物转化淫羊藿中4种黄酮苷[J]. 中成药, 2016, 38(9):1984-1990.

37. 张初瑜陈素红吴素香. 一测多评法测定复方人参片中的8种苷类成分[J]. 中国现代应用药学 2018 35(05):90-96.

36. 高霞, 陈彦, 王莹,等. 糊精湿法制粒对淫羊藿总黄酮酶解的影响[J]. 中成药, 2014, 36(007):1392-1397.

35. 高霞, 刘璇, 陈彦,等. 淫羊藿总黄酮的生物转化过程分析[J]. 中国中药杂志, 2013, 38(23):4079.

34. 刘聪燕, 高霞, 陈彦,等. 淫羊藿总黄酮在骨质疏松大鼠体内的药动学行为[J]. 中成药, 2017, 39(008):1595-1600.

33. 刘聪燕, 高霞, 黄萌萌,等. 淫羊藿总黄酮仿生酶解肠溶胶囊的制备及评价[J]. 中草药, 2016(20).

32. 张燕. 大孔吸附树脂分离纯化淫羊藿EF5黄酮[J]. 北方药学, 2015, 000(011):11-13.

31. 刘聪燕高霞陈彦等. 仿生酶解肠溶胶囊提高淫羊藿总黄酮口服生物利用度的可行性研究[J]. 中国医药工业杂志 2016(9期):1158-1164.

30. 杨成梓范兴包侠萍等. HPLC同时测定芪骨胶囊中5种成分的含量[J]. 中国实验方剂学杂志 2015 021(016):60-63.

29. 李婧,王英哲,刘玉翠,景志贤,闫莉,郭俊杰,姜大成,肖井雷.地理环境因子对朝鲜淫羊藿黄酮类成分空间分布影响的探测分析[J].中国中药杂志,2019,44(24):5368-5374.

28. 王莹高霞陈彦等. 卡波姆对淫羊藿总黄酮酶解效果的影响[J]. 中国实验方剂学杂志 2014 20(009):1-5.

27. 范兴, 杨成梓, 包侠萍,等. 芪骨胶囊HPLC指纹图谱研究[J]. 中草药, 2014, 045(009):1257-1261.

26. 涂艳, 熊莉娜, 柳湘洁,等. 淫羊藿苷对成骨细胞成骨分化的影响及Wnt/-catenin信号系统的关系研究[J]. 中国中医急症, 2017, 26(003):448-450.

25. 王艺璇李海涛刘顺等. 参葵通脉颗粒的质量标准研究[J]. 中药新药与临床药理 2020年31卷8期 984-989页 ISTIC PKU CSCD CA 2020.

24. 郭双双郑芳芳可丛雪等. 乳酸片球菌AS1.2696来源的α-L-鼠李糖苷酶酶学性质分析[J]. 食品科学 2019 040(004):160-169.

23. 程素盼张敏敏梁琰等. HPLC-DAD-ESI-TOF/MS法分析安神补脑液中化学成分[J]. 中成药 2019 041(004):743-748.

22. 赵岩, 侯莹莹, 唐国胜,等. 炮制前后淫羊藿不同提取物对ACE、α-葡萄糖苷酶的抑制活性及对亚硝酸根的清除活性研究[J]. 药物分析杂志, 2015(8期):1329-1334.

21. 刘玉萍, 丁学芳, 黄萌萌,等. 淫羊藿苷在不同骨质疏松大鼠模型中肠道吸收代谢研究[J]. 中国中药杂志, 2016(13):2532-2537.

20. 李瑞云刘聪燕许婷等. 交联纳米SiO_2固定化蜗牛酶的制备表征及转化淫羊藿苷研究[J]. 中草药 2019 v.50;No.655(20):57-63.

19. 洪雅丹张凌风潘娉娉等. HPLC法同时测定淫羊藿-骨碎补药对中7种成分[J]. 中成药 2019 041(006):1316-1321.

18. 杨轶舜张彤丁越等. 3种淫羊藿苷次生产物的制备及HPLC测定[J]. 中成药 2020 042(003):779-782.

17. 何玉琼, 赵璐, 沈燚,等. 淫羊藿苷对铁超载模型小鼠骨代谢的影响[J]. 药学学报, 2018(7).

16. 杨芬, 刘彦礼, 闫岩,等. 淫羊藿苷对经血源性子宫内膜干细胞成心肌样细胞分化的影响[J]. 中国细胞生物学学报, 2016(11):1373-1381.

15. 鞠静, 谭人千, 钟勇,等. 淫羊藿苷对气管切开模型大鼠早期β-防御素-2和T细胞亚群的影响[J]. 中南大学学报:医学版, 2020(1):1-7.

14. 邓淑蓉, 潘宇政, 彭玲玲,等. 淫羊藿苷对气管切开插管大鼠肺部肥大细胞活性及炎性反应的影响[J]. 中华中医药杂志, 2018, 033(004):1594-1597.

13. 郭艳霞. 淫羊藿苷对去卵巢大鼠骨质疏松症的保护机制研究[J]. 四川中医, 2017, 035(007):63-65.

12. 朱彤彤, 黄连弟, 李俊玮,等. 淫羊藿苷对去卵巢大鼠骨质疏松症的保护作用及其机制[J]. 吉林大学学报(医学版), 2016, 42(005):915-919.

11. 周勇, 刘晶, 陈刚. 淫羊藿苷对D-半乳糖诱导的脑衰老模型小鼠皮层线粒体自噬的影响[J]. 中华中医药杂志, 2019, v.34(12):156-160.

10. 周勇,刘晶,陈刚.淫羊藿苷对D-半乳糖诱导的脑衰老模型小鼠p53/p21信号通路的影响[J].中华中医药学刊,2019,37(09):2159-2162+2316.

9. 鞠静, 彭玲玲, 潘宇政,等. 淫羊藿苷及宝藿苷I对气管切开模型大鼠肺组织病理学及炎症因子的影响[J]. 中国实验动物学报, 2019, 27(3).

8. 徐永明, 徐宏光, 张晓玲,等. 淫羊藿素药物在终板软骨细胞退变中的保护作用研究[J]. 赤峰学院学报(自然版), 2016(16):54-57.

7. 林思文, 李雪芹, 刘素云,等. 淫羊藿素联合阿霉素对人骨肉瘤MG-63细胞抑制作用的体外研究[J]. 中国中西医结合杂志, 2016(36):0729-734.

6. 刘玉亮, 梁广胜, 魏强强,等. 淫羊藿总黄酮及淫羊藿素体外抗骨肉瘤的研究[J]. 中成药, 2013, 35(010):2072-2077.

5. 彭静, 马益华, 陈彦,等. 微乳化-凝胶法制备微球固定化蜗牛酶并生物转化淫羊藿苷研究[J]. 中草药, 2015, 46(22):3326-3332.

4. 彭静, 马益华, 陈彦,等. 固定化β-葡萄糖苷酶和蜗牛酶生物转化淫羊藿苷效率的比较研究[J]. 药学学报, 2015(12期):1652-1659.

3. 查琳赵岩祝洪艳等. 人参茎叶总皂苷脂质体与水溶液在大鼠体内的血药浓度及药代动力学参数对比分析[J]. 中国中药杂志 2017(10).

2. 谢媛媛彭灵苏加坤等. 中药淫羊藿薄层色谱鉴别方法的建立[J]. 中药与临床 2017(04):20-24.

1. 侯剑伟丁越张彤等. HPLC-DAD法同时测定调更汤中3个活性成分[J]. 中成药 2014 36(7):1454-1457.